Advanced search    

Search: Oncology

70,426 papers found. Showing first 1,000 results.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Controversies in Gynaecologic Oncology

of progress in any field of human endeavour—gynaecologic oncology is no exception. Because different individuals or groups of individuals hold divergent opinions on a subject, they, or others, are ... apparent that there are no blacks (or whites) but only shades of grey. It is in the spirit of ‘shades of grey’ that we present to you this special issue of Indian Journal of Gynaecologic Oncology on the

Imaging the multiple facets of immuno-oncology

Bimmuno-oncology^ has revolutionized cancer therapy, with several antibodies demonstrating survival improvements in a variety of cancers [ 1–3 ]. The most studied antibodies [ 1, 2 ] target PD-1, a

Correction to: Metastasectomy for Tumor-Infiltrating Lymphocytes: An Emerging Operative Indication in Surgical Oncology

Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute , Pittsburgh, PA , USA 1 Department of Surgery, Yale University School of

Geriatric oncology in Spain: survey results and analysis of the current situation

Introduction Geriatric oncology (GO) is a discipline that focuses on the management of elderly patients with cancer. The Spanish Society of Medical Oncology (SEOM) created a Working group dedicated ... Institut Catala` D'Oncologia-L'Hospitalet , Barcelona , Spain 1 Medical Oncology Unit. Hospital Llu ́ıs Alcany ́ıs, Crta Xa`tiva A Silla Km 2, Xa`tiva , 46800 Valencia , Spain 2 & R. Girone ́s 3 Hospital

Metastasectomy for Tumor-Infiltrating Lymphocytes: An Emerging Operative Indication in Surgical Oncology

timely manner. Eligible candidates for ACT should demonstrate adequate performance status (Eastern Cooperative Oncology Group [ECOG] 0 or 1). A commonly used lymphodepleting regimen includes ... aAdditional details of each trial can be found by searching trial number at ECOG Eastern Cooperative Oncology Group, HIV human immunodeficiency virus, HBV hepatitis B virus, HCV

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer

the Japan Society of Gynecologic Oncology (JSGO) guidelines for the treatment of vulvar cancer and vaginal cancer was published in 2015 in Japanese. Objective The JSGO committee decided to publish the ... vaginal cancer are rare tumors, they actually constitute the fourth and fifth most common cancers in the gynecologic oncology field. However, there are no established treatment principles or guidelines to

Cervical cancer patients presentation and survival in the only oncology referral hospital, Ethiopia: a retrospective cohort study

Women infected with Human Immune Deficiency Virus (HIV) are assumed to be at higher risk of developing Cervical Cancer (CC). This is due to a rapid progression of pre-invasive to invasive lesions. However, evidences suggest, due to the availability of antiretroviral therapy (ART) and care services; an improved survival and treatment outcome of CC patients (CCPs) with HIV infection ...

Development of chemotherapeutics in oncology: is there anything new?

development of classical cytostatic drugs and their indications? Despite living in the area of “modern oncology”, there are indeed indications where chemotherapy remains the mainstay of treatment in all stages ... and T. Winder declare that they have no competing interests. Holger Rumpold Thomas Winder 7 For latest news from international oncology congresses see: memo-inoncology

Identifying cisplatin-induced kidney damage in paediatric oncology patients

. investigations and biomarkers) and the importance of magnesium homeostasis and supplementation. Cisplatin; Paediatrics; Oncology; Nephrotoxicity; Tubular toxicity; Magnesium Introduction Improvements in the

Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research

dynamically track tumor evolution and to adapt molecularly targeted therapy according to the emergence of tumor clonal variants is shaping modern medical oncology., In order to better describe this new ... , Trieste , Italy 5 Senior Group Leader Foundation Institute FIRC Molecular Oncology (IFOM) Milan , Milan , Italy 6 and Department of Medicine and Surgery University Milano-Bicocca , Milan , Italy 7

Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA

) receiving ziv-aflibercept in non-academic, community oncology practices in the USA. De-identified electronic medical records from Vector Oncology and Altos Solutions databases were analysed. We identified 218

Neuro-Oncology: Current Concepts and Emerging Therapeutics

, Birmingham, AL , USA - Having the opportunity to serve as Guest Editors of this issue of Neurotherapeutics on neuro-oncology forced by design a critical consideration of current knowledge, the most impactful ... advances in evidence-based diagnostics and therapeutics, and the most promising basic and clinical research directions. Neuro-oncology is expansive from almost all perspectives. There are over 100 distinct

European Association of Neuro-Oncology

„Option, nicht Standard“ 0 Ärztlicher Direktor, Neurologische Klinik , Universitätsklinikum Heidelberg 1 Neuro-Oncology Practice Die Zeitschrift Neuro-Oncology Practice wird gemeinsam von EANO ... lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16(7):e322-32. - An der Therapie für Patienten mit einem Glioblastom hat sich in den

Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

cancer patients by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). An expert group was put together by the AGIHO to update the existing ... Internal Medicine - Hematology and Oncology - Mannheim University Hospital, University of Heidelberg , Heidelberg , Germany 1 Deutsches Beratungszentrum für Hygiene, BZH GmbH , Freiburg , Germany 2 1st

Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial

, University Medical Center Utrecht , Utrecht , The Netherlands 4 Department of Pharmaceutical Sciences, Utrecht University , Utrecht , The Netherlands 5 Department of Medical Oncology and Clinical Pharmacology

Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses

antiemetic guidelines is suboptimal. Oncology nurses, as part of a multidisciplinary team, can help promote appropriate antiemetic prophylaxis. Therefore, nurses were surveyed to assess antiemetic guideline

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation

Background New immuno-oncology (I-O) therapies that harness the immune system to fight cancer call for a re-examination of the traditional parametric techniques used to model survival from clinical ... option for survival analysis by health technology assessment bodies when considering effectiveness and cost-effectiveness. 1 Introduction New drugs under the class of immuno-oncology (I-O) compounds have

Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Hospital, Vall d'Hebron Institute of Oncology (VHIO) , Passeig de la Vall d'Hebron, 119-129, 08035 Barcelona , Spain 1 Medical Oncology Department, Instituto Valenciano de Oncolog ́ıa , Valencia , Spain 2